Analysts cut price targets and issued rating notes for BETA BIONICS, which was required to file transaction disclosures with the SEC.
2 reports, 1 independent
Updated Fri 00:00
No new developments lately
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analysts cut price targets and issued rating notes for BETA BIONICS, which was required to file transaction disclosures with the SEC.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- BETA BIONICS, INC.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
- Analyst coverage for Vornado Realty Trust resulted in rating changes and price target adjustments from firms including Citigroup, Morgan Stanley, and Truist Financial.
- Financial institutions, including Wells Fargo and Bank of America, issued rating updates and filed reports regarding institutional stake reductions with the SEC.
- Financial institutions including Truist Financial, Royal Bank of Canada, and Renaissance Technologies issued rating updates and reported institutional holdings changes to the SEC.
- Truist Financial decreased its price target on Leggett & Platt.